Silence Therapeutics (SLN) Cash from Operations Growth (1y) (2025 - 2026)
Silence Therapeutics (SLN) Cash from Operations Growth (1y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,538.84 Bn | 65,538.56 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 469.46 Bn | 464.67 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 122.69 Bn | 115.45 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 70.41 Bn | 61.65 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.84 Bn | 62.84 Bn | - | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | 158.60% |
| 10 | Silence Therapeutics | 1.66 Bn | 1.53 Bn | 411,000.00 | -26.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.76% |
| Dec 31, 2025 | 36.99% |
| Sep 30, 2025 | 57.50% |
| Jun 30, 2025 | -302.87% |
| Mar 31, 2025 | -34.63% |